Schedule 13D ownership disclosure
Anchiano Therapeutics Ltd.
Security class unavailable · CUSIP: 03280X102
Event date: 2019-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,848,200
- Percent of class
- 4.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-19-001001
- Form type
- SC 13D
- Filer
- Anchiano Therapeutics Ltd./ADR
- CIK
- CIK 1762418
- Filed
- Feb 22, 2019
- Reporting period
- Feb 12, 2019
- Description
- Schedule 13D beneficial ownership